Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.370
-0.070 (-1.58%)
Aug 14, 2025, 1:53 PM - Market open
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $269.89 million as of August 14, 2025. Its market cap has decreased by -3.41% in one year.
Market Cap
269.89M
Enterprise Value
24.75M
1-Year Change
-3.41%
Ranking
Category
Stock Price
$4.37
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $269.89M, a decrease of -68.07%. That is a compound annual growth rate of -24.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 274.21M | -35.69% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |